betway必威登陆网址 (betway.com )学报››2022,Vol. 43››Issue (3): 166-171.DOI:10.3969/j.issn.2097-0005.2022.03.002
冯芮1,2(), 潘飞3, 王晓玉4, 陈浩月4, 陈悦霞4, 郑遵成4(
)
收稿日期:
2021-09-17出版日期:
2022-03-25发布日期:
2022-04-11通讯作者:
郑遵成作者简介:
冯芮,硕士研究生,研究方向:骨科、神经疾病康复,E-mail:frwin521@126.com。Rui FENG1,2(), Fei PAN3, Xiaoyu WANG4, Haoyue CHEN4, Yuexia CHEN4, Zuncheng ZHENG4(
)
Received:
2021-09-17Online:
2022-03-25Published:
2022-04-11Contact:
Zuncheng ZHENG摘要:
探讨嗅鞘细胞(olfactory ensheathing cells,OECs)移植后大鼠脊髓组织不同时期Wnt信号分子Wnt-1、β-catenin、GSK-3β、c-myc在损伤部位脊髓的表达变化。
乳鼠嗅球制备OECs,90只成年雄性SD大鼠随机分为3组,以脊髓T10节段为中心,大鼠脊髓损伤模型制备采用Allens'打击法。空白组:T9-11椎板去除;损伤组:T10脊髓损伤;移植组:T10脊髓损伤,OECs移植。分别于术后1、3、5、7、14 d,每组各取3只大鼠,取以损伤区为中心上下1.5 cm范围内(空白组取椎板去除部位)的脊髓组织,提取总RNA,采用定量聚合酶链反应(quantitative polymerase chain reaction,qPCR)检测脊髓组织中Wnt-1、β-catenin、GSK-3β、c-myc的表达量;术前及术后第7天、第14天观察BBB评分,术后第7天做免疫组化,观察脊髓结构变化。
移植7 d和14 d后,移植组运动功能评分(basso beattie bresnahan,BBB)高于损伤组,差异有统计学意义(P< 0.01)。qPCR结果显示空白组不同时间点各信号分子表达稳定,趋势较为平稳;损伤组Wnt-1、GSK-3β与c-myc总体呈下调趋势,β-catenin有小幅上升,但都呈明显抑制状态;与损伤组比较,移植组除c-myc小幅上调外,Wnt-1、β-catenin与GSK-3β均呈较高表达,明显减轻了损伤后的抑制状态。
脊髓损伤后Wnt/β-catenin通路被抑制,经OECs移植后,大鼠运动功能明显恢复,且Wnt/β-catenin通路抑制状态明显减轻。
冯芮, 潘飞, 王晓玉, 陈浩月, 陈悦霞, 郑遵成. 嗅鞘细胞移植对脊髓损伤大鼠Wnt/β-catenin信号分子影响[J]. betway必威登陆网址 (betway.com )学报, 2022, 43(3): 166-171.
Rui FENG, Fei PAN, Xiaoyu WANG, Haoyue CHEN, Yuexia CHEN, Zuncheng ZHENG. Effect of olfactory ensheathing cell transplantation on Wnt/β-catenin signaling molecules in rats with spinal cord injury[J]. Journal of Shandong First Medical Unversity & Shandong Academy of Medical Sciences, 2022, 43(3): 166-171.
引物名称 | 引物序列(5'→3') |
---|---|
Wnt1-F | CAAGATAGTCAACCGAGGCT |
Wnt1-R | GTAGTCGCAGGTGCAGGATT |
β-catenin-F | TTTCCCAGTCCTTCACGCAA |
β-catenin-R | GCGCTGGACATTAGTGGGAT |
GSK-3β-F | AAGCGATTTAAGAACCGAGAGC |
GSK-3β-R | GTCCAGCACCAGGTTAAGGT |
c-myc-F | CTCGGTGCAGCCCTATTTCA |
c-myc-R | TAGCGACCGCAACATAGGAC |
GAPDH-F | GCACCGTCAAGGCTGAGAAC |
GAPDH-R | TGGTGAAGACGCCAGTGGA |
表1Wnt-1、β-catenin、GSK-3β、c-myc及内参GAPDH引物序列
引物名称 | 引物序列(5'→3') |
---|---|
Wnt1-F | CAAGATAGTCAACCGAGGCT |
Wnt1-R | GTAGTCGCAGGTGCAGGATT |
β-catenin-F | TTTCCCAGTCCTTCACGCAA |
β-catenin-R | GCGCTGGACATTAGTGGGAT |
GSK-3β-F | AAGCGATTTAAGAACCGAGAGC |
GSK-3β-R | GTCCAGCACCAGGTTAAGGT |
c-myc-F | CTCGGTGCAGCCCTATTTCA |
c-myc-R | TAGCGACCGCAACATAGGAC |
GAPDH-F | GCACCGTCAAGGCTGAGAAC |
GAPDH-R | TGGTGAAGACGCCAGTGGA |
时间 | 空白组 | 损伤组 | 移植组 | F | P |
---|---|---|---|---|---|
术前 | 21.00 ± 0.00 | 21.00 ± 0.00 | 21.00 ± 0.00 | ||
术后7 d | 20.30 ± 0.675a | 3.60 ± 0.699ch | 3.40 ± 1.08eij | 4 581.237 | < 0.001 |
术后14 d | 20.90 ± 0.316b | 5.90 ± 0.738d | 13.2 ± 2.09fgklm | 13 140.167 | < 0.001 |
F | 21 191.556 | 136.456 | 931.918 | ||
P | < 0.001 | < 0.001 | < 0.001 |
表23组大鼠移植后BBB评分
时间 | 空白组 | 损伤组 | 移植组 | F | P |
---|---|---|---|---|---|
术前 | 21.00 ± 0.00 | 21.00 ± 0.00 | 21.00 ± 0.00 | ||
术后7 d | 20.30 ± 0.675a | 3.60 ± 0.699ch | 3.40 ± 1.08eij | 4 581.237 | < 0.001 |
术后14 d | 20.90 ± 0.316b | 5.90 ± 0.738d | 13.2 ± 2.09fgklm | 13 140.167 | < 0.001 |
F | 21 191.556 | 136.456 | 931.918 | ||
P | < 0.001 | < 0.001 | < 0.001 |
术后时间(d) | 空白组 | 损伤组 | 移植组 | F | P |
---|---|---|---|---|---|
1 | 1.018 ± 0.005 | 0.542 ± 0.156※ | 0.248 ± 0.046※※ | 161 388.967 | 0.002 |
3 | 1.004 ± 0.012 | 0.538 ± 0.026※ | 0.249 ± 0.002※※ | 423.574 | 0.034 |
5 | 1.002 ± 0.020 | 0.428 ± 0.020 | 0.395 ± 0.010*※ | 344.620 | 0.038 |
7 | 1.000 ± 0.034 | 0.275 ± 0.010***※ | 0.590 ± 0.025***※※ | 939.691 | 0.023 |
14 | 1.008 ± 0.100 | 0.290 ± 0.549* | 0.159 ± 0.012 | 188 316.868 | 0.002 |
F | 269 789.499 | 54 986.184 | 47 837.782 | ||
P | 0.001 | 0.003 | 0.003 |
表3Wnt-1不同时间点mRNA表达变化
术后时间(d) | 空白组 | 损伤组 | 移植组 | F | P |
---|---|---|---|---|---|
1 | 1.018 ± 0.005 | 0.542 ± 0.156※ | 0.248 ± 0.046※※ | 161 388.967 | 0.002 |
3 | 1.004 ± 0.012 | 0.538 ± 0.026※ | 0.249 ± 0.002※※ | 423.574 | 0.034 |
5 | 1.002 ± 0.020 | 0.428 ± 0.020 | 0.395 ± 0.010*※ | 344.620 | 0.038 |
7 | 1.000 ± 0.034 | 0.275 ± 0.010***※ | 0.590 ± 0.025***※※ | 939.691 | 0.023 |
14 | 1.008 ± 0.100 | 0.290 ± 0.549* | 0.159 ± 0.012 | 188 316.868 | 0.002 |
F | 269 789.499 | 54 986.184 | 47 837.782 | ||
P | 0.001 | 0.003 | 0.003 |
术后时间(d) | 空白组 | 损伤组 | 移植组 | F | P |
---|---|---|---|---|---|
1 | 1.009 ± 0.001 | 0.829 ± 0.127 | 2.086 ± 0.100※※ | 53 047 036.800 | < 0.001 |
3 | 1.002 ± 0.086 | 0.774 ± 0.035※ | 2.811 ± 0.030※※ | 129 080.212 | 0.002 |
5 | 1.002 ± 0.074 | 0.933 ± 0.030 | 2.295 ± 0.062※※ | 3 252.773 | 0.012 |
7 | 1.004 ± 0.055 | 0.953 ± 0.040 | 3.636 ± 0.165**※※ | 3 914.371 | 0.011 |
14 | 1.020 ± 0.014 | 0.930 ± 0.030 | 2.735 ± 0.187※※ | 17 382.195 | 0.005 |
F | 1 457 948.810 | 963.709 | 14 987.272 | ||
P | 0.001 | 0.023 | 0.006 |
表4β-catenin不同时间点mRNA表达变化
术后时间(d) | 空白组 | 损伤组 | 移植组 | F | P |
---|---|---|---|---|---|
1 | 1.009 ± 0.001 | 0.829 ± 0.127 | 2.086 ± 0.100※※ | 53 047 036.800 | < 0.001 |
3 | 1.002 ± 0.086 | 0.774 ± 0.035※ | 2.811 ± 0.030※※ | 129 080.212 | 0.002 |
5 | 1.002 ± 0.074 | 0.933 ± 0.030 | 2.295 ± 0.062※※ | 3 252.773 | 0.012 |
7 | 1.004 ± 0.055 | 0.953 ± 0.040 | 3.636 ± 0.165**※※ | 3 914.371 | 0.011 |
14 | 1.020 ± 0.014 | 0.930 ± 0.030 | 2.735 ± 0.187※※ | 17 382.195 | 0.005 |
F | 1 457 948.810 | 963.709 | 14 987.272 | ||
P | 0.001 | 0.023 | 0.006 |
术后时间(d) | 空白组 | 损伤组 | 移植组 | F | P |
---|---|---|---|---|---|
1 | 1.004 ± 0.005 | 0.959 ± 0.042 | 1.687 ± 0.206 | 310 956.261 | 0.001 |
3 | 1.008 ± 0.081* | 0.456 ± 0.030※ | 2.853 ± 0.079※※ | 218 814.669 | 0.002 |
5 | 1.052 ± 0.075* | 0.471 ± 0.012*※ | 2.989 ± 0.100※※ | 3 082.888 | 0.013 |
7 | 1.034 ± 0.098* | 0.481 ± 0.010※ | 1.281 ± 0.015**※※ | 2 895.840 | 0.013 |
14 | 1.007 ± 0.001* | 0.319 ± 0.030*※ | 1.823 ± 0.047***※※ | 1 313 629.730 | 0.001 |
F | 394 009.527 | 163 105.096 | 7 190.294 | ||
P | 0.001 | 0.002 | 0.008 |
表5GSK-3β不同时间点mRNA表达变化
术后时间(d) | 空白组 | 损伤组 | 移植组 | F | P |
---|---|---|---|---|---|
1 | 1.004 ± 0.005 | 0.959 ± 0.042 | 1.687 ± 0.206 | 310 956.261 | 0.001 |
3 | 1.008 ± 0.081* | 0.456 ± 0.030※ | 2.853 ± 0.079※※ | 218 814.669 | 0.002 |
5 | 1.052 ± 0.075* | 0.471 ± 0.012*※ | 2.989 ± 0.100※※ | 3 082.888 | 0.013 |
7 | 1.034 ± 0.098* | 0.481 ± 0.010※ | 1.281 ± 0.015**※※ | 2 895.840 | 0.013 |
14 | 1.007 ± 0.001* | 0.319 ± 0.030*※ | 1.823 ± 0.047***※※ | 1 313 629.730 | 0.001 |
F | 394 009.527 | 163 105.096 | 7 190.294 | ||
P | 0.001 | 0.002 | 0.008 |
术后时间(d) | 空白组 | 损伤组 | 移植组 | F | P |
---|---|---|---|---|---|
1 | 1.069 ± 0.005 | 1.604 ± 0.103※ | 0.485 ± 0.061※※ | 146 153 691.000 | < 0.001 |
3 | 1.009 ± 0.13 | 1.971 ± 0.126※ | 0.229 ± 0.025※※ | 759.476 | 0.026 |
5 | 1.003 ± 0.27* | 0.697 ± 0.015**※ | 0.246 ± 0.015※※ | 10 054.208 | 0.007 |
7 | 1.192 ± 0.27 | 0.956 ± 0.020*※ | 0.887 ± 0.030*※ | 236 729.289 | 0.001 |
14 | 1.029 ± 0.006* | 0.829 ± 0.029**※ | 0.262 ± 0.092※※ | 19 358 006.800 | < 0.001 |
F | 282 809.911 | 253.439 | 193.011 | ||
P | 0.001 | 0.044 | 0.051 |
表6c-myc不同时间点mRNA表达变化
术后时间(d) | 空白组 | 损伤组 | 移植组 | F | P |
---|---|---|---|---|---|
1 | 1.069 ± 0.005 | 1.604 ± 0.103※ | 0.485 ± 0.061※※ | 146 153 691.000 | < 0.001 |
3 | 1.009 ± 0.13 | 1.971 ± 0.126※ | 0.229 ± 0.025※※ | 759.476 | 0.026 |
5 | 1.003 ± 0.27* | 0.697 ± 0.015**※ | 0.246 ± 0.015※※ | 10 054.208 | 0.007 |
7 | 1.192 ± 0.27 | 0.956 ± 0.020*※ | 0.887 ± 0.030*※ | 236 729.289 | 0.001 |
14 | 1.029 ± 0.006* | 0.829 ± 0.029**※ | 0.262 ± 0.092※※ | 19 358 006.800 | < 0.001 |
F | 282 809.911 | 253.439 | 193.011 | ||
P | 0.001 | 0.044 | 0.051 |
1 | Kumar R, Lim J, Mekary RA, et al. Traumatic spinal injury: global epidemiology and worldwide volume[J]. World Neurosurg, 2018, 113: e345. |
2 | Dumont RJ, Okonkwo DO, Verma S, et al. Acute spinal cord injury, part I: pathophysiologic mechanisms[J]. Clin Neuropharmacol, 2001, 24(5): 254. |
3 | Allison DJ, Ditor DS. Immune dysfunction and chronic inflammation following spinal cord injury[J]. Spinal Cord, 2015, 53(1): 14. |
4 | Gilmour AD, Reshamwala R, Wright AA, et al. Optimizing olfactory ensheathing cell transplantation for spinal cord injury repair[J]. J Neurotrauma, 2020, 37(5): 817. |
5 | Steinhart Z, Angers S. Wnt signaling in development and tissue homeostasis[J]. Development, 2018, 145(11): dev146589. |
6 | González-Fernández C, Fernández-Martos CM, Shields SD, et al. Wnts are expressed in the spinal cord of adult mice and are differentially induced after injury[J]. J Neurotrauma, 2014, 31(6): 565. |
7 | Selvarajah S, Hammond ER, Haider AH, et al. The burden of acute traumatic spinal cord injury among adults in the United States: an update[J]. J Neurotrauma, 2014, 31(3): 228. |
8 | Myers JB, Lenherr SM, Stoffel JT, et al. Patient reported bladder related symptoms and quality of life after spinal cord injury with different bladder management strategies[J]. J Urol, 2019, 202(3): 574. |
9 | Devivo MJ. Epidemiology of traumatic spinal cord injury: trends and future implications[J]. Spinal Cord, 2012, 50(5): 365. |
10 | Gómez RM, Sánchez MY, Portela-Lomba M, et al. Cell therapy for spinal cord injury with olfactory ensheathing glia cells (OECs)[J]. Glia, 2018, 66(7): 1267. |
11 | 陈琳, 贺西京, 黄红云, 等. 嗅鞘细胞髓内移植修复完全性晚期脊髓损伤手术多中心比较[J]. 神经损伤与功能重建, 2020, 15(2): 103. |
12 | Zheng ZC, Liu GF, Chen YX, et al. Olfactory ensheathing cell transplantation improves sympathetic skin responses in chronic spinal cord injury[J]. Neural Regen Res, 2013, 8(30): 2849. |
13 | Zheng ZC, Du XJ, Zhang KG, et al. Olfactory ensheathing cell transplantation inhibits P2X4 receptor overexpression in spinal cord injury rats with neuropathic pain[J]. Neurosci Lett, 2017, 651: 171. |
14 | Fernández-Martos CM, González-Fernández C, González P, et al. Differential expression of Wnts after spinal cord contusion injury in adult rats[J]. Plos One, 2011, 6(11): e27000. |
15 | Krishnamurthy N, Kurzrock R. Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors[J]. Cancer Treat Rev, 2018, 62: 50. |
16 | Mikels AJ, Nusse R. Wnts as ligands: processing, secretion and reception[J]. Oncogene, 2006, 25(57): 7461. |
17 | Xu DW, Zhao W, Pan G, et al. Expression of Nemo-like kinase after spinal cord injury in rats[J]. J Mol Neurosci, 2014, 52(3): 410. |
18 | Yang JS, Wei HX, Chen PP, et al. Roles of Eph/ephrin bidirectional signaling in central nervous system injury and recovery[J]. Exp Ther Med, 2018, 15(3): 2219. |
No related articles found! |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||